Update shared on04 Sep 2025
With consensus revenue growth and discount rate forecasts for Bath & Body Works both remaining stable, the analyst fair value target also stayed unchanged at $40.73.
What's in the News
- Bath & Body Works revised its full-year 2025 sales growth guidance to 1.5%-2.7% (from 1%-3%) and lowered EPS expectations to $3.28–$3.53, below fiscal 2024’s $3.61.
- The company repurchased 8 million shares (3.74% of shares, $238.71 million) under its recent buyback program.
- Bath & Body Works launched a Disney Villains fragrance collection, deepening its partnership with Disney for broader product launches and international reach.
- The brand began selling in over 600 college campus stores nationwide, targeting Gen Z and capitalizing on strong teen brand recognition.
- The Summerween fragrance collection launched with early access for loyalty members, featuring new and returning products including men's and Halloween-themed scents.
Valuation Changes
Summary of Valuation Changes for Bath & Body Works
- The Consensus Analyst Price Target remained effectively unchanged, at $40.73.
- The Consensus Revenue Growth forecasts for Bath & Body Works remained effectively unchanged, at 3.1% per annum.
- The Discount Rate for Bath & Body Works remained effectively unchanged, at 10.34%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.